yeast as probiotics –Saccharomyces boulardii D Czerucka, T Piche, P Rampal Alimentary pharmacology & therapeutics 26 (6), 767-778, 2007 | 822 | 2007 |
Human health and ocean pollution PJ Landrigan, JJ Stegeman, LE Fleming, D Allemand, DM Anderson, ... Annals of global health 86 (1), 2020 | 609 | 2020 |
Experimental effects of Saccharomyces boulardii on diarrheal pathogens D Czerucka, P Rampal Microbes and infection 4 (7), 733-739, 2002 | 326 | 2002 |
Saccharomyces boulardii Preserves the Barrier Function and Modulates the Signal Transduction Pathway Induced in Enteropathogenic Escherichia coli-Infected … D Czerucka, S Dahan, B Mograbi, B Rossi, P Rampal Infection and immunity 68 (10), 5998-6004, 2000 | 280 | 2000 |
Saccharomyces boulardii Interferes with Enterohemorrhagic Escherichia coli-Induced Signaling Pathways in T84 Cells S Dahan, G Dalmasso, V Imbert, JF Peyron, P Rampal, D Czerucka Infection and immunity 71 (2), 766-773, 2003 | 258 | 2003 |
The putative role of inflammation in the irritable bowel syndrome SM Collins, T Piche, P Rampal Gut 49 (6), 743-745, 2001 | 238 | 2001 |
Saccharomyces boulardii inhibits inflammatory bowel disease by trapping T cells in mesenteric lymph nodes G Dalmasso, F Cottrez, V Imbert, P Lagadec, JF Peyron, P Rampal, ... Gastroenterology 131 (6), 1812-1825, 2006 | 227 | 2006 |
Saccharomyces boulardii does not prevent relapse of Crohn's disease A Bourreille, G Cadiot, G Le Dreau, D Laharie, L Beaugerie, JL Dupas, ... Clinical gastroenterology and hepatology 11 (8), 982-987, 2013 | 221 | 2013 |
Saccharomyces boulardii inhibits secretagogue-mediated adenosine 3′, 5′-cyclic monophosphate induction in intestinal cells D Czerucka, I Roux, P Rampal Gastroenterology 106 (1), 65-72, 1994 | 202 | 1994 |
Lactobacillus casei DN-114 001 inhibits the increase in paracellular permeability of enteropathogenic Escherichia coli-infected T84 cells N Parassol, M Freitas, K Thoreux, G Dalmasso, R Bourdet-Sicard, ... Research in microbiology 156 (2), 256-262, 2005 | 197 | 2005 |
Effects of Saccharomyces boulardii on fecal short-chain fatty acids and microflora in patients on long-term total enteral nutrition SM Schneider, F Girard-Pipau, J Filippi, X Hébuterne, D Moyse, ... World journal of gastroenterology: WJG 11 (39), 6165, 2005 | 173 | 2005 |
Quality of life in long-term home enteral nutrition patients SM Schneider, I Pouget, P Staccini, P Rampal, X Hebuterne Clinical Nutrition 19 (1), 23-28, 2000 | 138 | 2000 |
Interaction of Saccharomyces boulardii with Salmonella enterica Serovar Typhimurium Protects Mice and Modifies T84 Cell Response to the Infection FS Martins, G Dalmasso, RME Arantes, A Doye, E Lemichez, P Lagadec, ... PLoS One 5 (1), e8925, 2010 | 136 | 2010 |
Endoscopic bilateral metal stent placement for malignant hilar stenoses: identification of optimal technique R Dumas, N Demuth, M Buckley, EP Peten, T Manos, JF Demarquay, ... Gastrointestinal endoscopy 51 (3), 334-338, 2000 | 130 | 2000 |
Chondrex (YKL-40), a potential new serum fibrosis marker in patients with alcoholic liver disease A Tran, S Benzaken, MC Saint-Paul, E Guzman-Granier, P Hastier, ... European journal of gastroenterology & hepatology 12 (9), 989-993, 2000 | 125 | 2000 |
Fatigue is associated with high circulating leptin levels in chronic hepatitis C T Piche, E Gelsi, SM Schneider, X Hebuterne, J Giudicelli, B Ferrua, ... Gut 51 (3), 434-439, 2002 | 119 | 2002 |
Enterohemorrhagic Escherichia coli Infection Induces Interleukin-8 Production via Activation of Mitogen-Activated Protein Kinases and the Transcription Factors NF … S Dahan, V Busuttil, V Imbert, JF Peyron, P Rampal, D Czerucka Infection and immunity 70 (5), 2304-2310, 2002 | 119 | 2002 |
Effect of ondansetron, a 5-HT3 receptor antagonist, on fatigue in chronic hepatitis C: a randomised, double blind, placebo controlled study T Piche, G Vanbiervliet, F Cherikh, Z Antoun, PM Huet, E Gelsi, ... Gut 54 (8), 1169-1173, 2005 | 118 | 2005 |
Acute renutrition by cyclic enteral nutrition in elderly and younger patients X Hébuterne, JF Broussard, P Rampal Jama 273 (8), 638-643, 1995 | 117 | 1995 |
Diversity of Saccharomyces boulardii CNCM I-745 mechanisms of action against intestinal infections D Czerucka, P Rampal World Journal of Gastroenterology 25 (18), 2188, 2019 | 116 | 2019 |